Jasper Therapeutics, Inc.Jasper Therapeutics, Inc.Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪314.73 M‬USD
−4.7463USD
‪−64.47 M‬USD
0.00USD
‪11.26 M‬
Beta (1Y)
3.88

About Jasper Therapeutics, Inc.


CEO
Ronald A. Martell
Headquarters
Redwood City
Founded
2018
FIGI
BBG00RBFC714
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Displays a symbol's price movements over previous years to identify recurring trends.